secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2026-06-02T10:31:58+00:00
Accession:  0001568651-26-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO
------------------------------------------------------------------------

- New role as Co-Founder & Advisor to CEO effective June 1, 2026; continues to serve on Board.
- Annual base salary set at $370,000; no longer eligible for annual bonus starting 2026.
- Will not receive future equity awards; existing equity continues to vest per original terms.
- No cash severance or subsidized healthcare upon termination of employment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/0001568651-26-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/oscr-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001568651-26-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer